Thievon John 4
4 · Adams Respiratory Therapeutics, Inc. · Filed Jan 30, 2007
Insider Transaction Report
Form 4
Thievon John
EVP, Commercial Operations
Transactions
- Sale
Common Stock
2007-01-29$44.84/sh−46$2,063→ 57 total - Sale
Common Stock
2007-01-29$44.73/sh−2$89→ 1,594 total - Sale
Common Stock
2007-01-29$44.74/sh−369$16,509→ 1,225 total - Sale
Common Stock
2007-01-29$44.82/sh−125$5,603→ 103 total - Sale
Common Stock
2007-01-29$44.68/sh−29$1,296→ 2,822 total - Sale
Common Stock
2007-01-29$44.69/sh−57$2,547→ 2,765 total - Sale
Common Stock
2007-01-29$44.79/sh−171$7,659→ 228 total - Sale
Common Stock
2007-01-29$44.72/sh−770$34,434→ 1,596 total - Sale
Common Stock
2007-01-29$44.71/sh−399$17,839→ 2,366 total - Sale
Common Stock
2007-01-29$44.75/sh−540$24,165→ 685 total - Sale
Common Stock
2007-01-29$44.77/sh−105$4,701→ 551 total - Sale
Common Stock
2007-01-29$44.78/sh−152$6,807→ 399 total
Footnotes (1)
- [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2006.